Get the Stockscreener App
3.8791
9.58%
-0.4109
Arcadia Biosciences Inc stock is traded at $3.8791, with a volume of 22,653.
It is down -9.58% in the last 24 hours and up +32.17% over the past month.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
See More
Previous Close:
$4.29
Open:
$3.5
24h Volume:
22,653
Relative Volume:
2.56
Market Cap:
$4.81M
Revenue:
$5.67M
Net Income/Loss:
$-13.98M
P/E Ratio:
-0.2745
EPS:
-14.13
Net Cash Flow:
$-15.30M
1W Performance:
+10.20%
1M Performance:
+32.17%
6M Performance:
-4.22%
1Y Performance:
+86.90%
1-Day Range:
$3.50
$4.28
1-Week Range:
$3.38
$4.86
52-Week Range:
$1.96
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Name
Arcadia Biosciences Inc
Sector
Industry
Phone
530-756-7077
Address
202 COUSTEAU PLACE, DAVIS, CA
Compare RKDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
3.8791 | 4.81M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
28.07 | 33.90B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
54.50 | 30.35B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.48 | 28.75B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
76.07 | 20.39B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.21 | 16.12B | 11.92B | 805.04M | 1.01B | 1.46 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-20 | Reiterated | H.C. Wainwright | Buy |
| May-12-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-09-15 | Initiated | Credit Suisse | Outperform |
| Jun-09-15 | Initiated | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Stock (RKDA) Latest News
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences Reports Strong Growth Amid Challenges - TipRanks
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ... - Yahoo Finance
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and Strategic Moves Amid Challenges - GuruFocus
Arcadia Biosciences: Q1 Earnings Snapshot - CT Insider
Earnings call transcript: Arcadia Biosciences sees Q1 2025 revenue rise 22% - Investing.com
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Arcadia Biosciences Q1 Earnings Preview - MSN
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Arcadia Climbs on Q1 Figures - Baystreet.ca
ARCADIA BIOSCIENCES Earnings Results: $RKDA Reports Quarterly Earnings - Nasdaq
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights | RKDA Stock News - GuruFocus
Arcadia Biosciences, Inc. SEC 10-Q Report - TradingView
Arcadia Biosciences reports Q1 revenue $1.2M vs $987k last yea - TipRanks
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Geode Capital Management LLC Takes $73,000 Position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) - Defense World
Halper Sadeh LLP, Arcadia Biosciences, Inc., The Interpublic Group of Companies, Inc., Omnicom Group Inc., Enterprise Bancorp, Inc. - Olean Times Herald
Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 - GuruFocus
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule - Nasdaq
Arcadia Biosciences (RKDA) Announces Date of First Quarter - GlobeNewswire
Mark Your Calendar: Arcadia Biosciences to Reveal Q1 2025 Financial Performance on May 8 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com India
Arcadia Biosciences regains IP rights, amends agreement - Investing.com
Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener
Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World
Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock - MSN
Arcadia Biosciences Earnings Call Highlights Zola Growth - TipRanks
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ... - Yahoo Finance
Arcadia Biosciences Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: Arcadia Biosciences Q4 2024 sees revenue growth By Investing.com - Investing.com Canada
Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
Arcadia Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights - Quantisnow
Arcadia Biosciences (RKDA) Expected to Announce Earnings on Thursday - Defense World
Arcadia Biosciences Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView
Arcadia Biosciences Inc Stock (RKDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Arcadia Biosciences Inc Stock (RKDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schaefer Thomas J. | Chief Executive Officer |
Feb 03 '25 |
Buy |
2.49 |
700 |
1,743 |
2,819 |
| Kawakami Mark | Chief Financial Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
1,981 |
| Schaefer Thomas J. | Chief Executive Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
2,119 |
1.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):